Latest Development Programs News

Macarthur Minerals Limited (ASX:MIO) has obtained Program of Work approval from the Western Australian Department of Mines, enabling bulk sampling and infrastructure development at its Lake Giles Iron Project. This milestone supports the company’s strategic progression toward potential production.

Strickland Metals Limited has reported promising first-pass diamond drilling results at the Obradov Potok prospect within its Rogozna Gold and Base Metals Project in Serbia, confirming significant lead-zinc-silver mineralisation consistent with proximity to a copper-gold skarn system.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Tamboran Resources Corporation has initiated a significant equity raise totaling approximately US$198 million to fund expanded drilling and development activities in the Beetaloo Basin. The capital raise includes a registered underwritten public offering and a pro rata entitlement offer, representing a 25% increase in shares on issue.

Lumos Diagnostics has entered a three-year contract manufacturing agreement with Micro-Pak to produce the Mold Analyzer system, marking a transition from development to commercial-scale manufacturing with an initial US$250,000 purchase order.

BluGlass Limited (ASX: BLG) has entered a A$1.3 million strategic collaboration with a Fortune 500 global data storage company to advance photonics research using its proprietary visible laser technology.

Tamboran Resources reports robust and stable gas production from its Shenandoah South 6H well, marking a key milestone ahead of planned gas sales in late 2026.

Following ASIC's final inquiry report, ASX unveils a comprehensive transformation plan focusing on governance, leadership, and risk management, alongside a significant capital charge.

Racura Oncology has enrolled the first patient in its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib to tackle resistance in EGFR-mutant non-small cell lung cancer. This milestone sets the stage for a multi-centre study aiming to improve treatment outcomes.

Electro Optic Systems secures two significant US contracts worth US$12 million for advanced Remote Weapon Systems, while progressing a conditional US$80 million Korean High Energy Laser contract with potential manufacturing shifts.

Brookside Energy has commenced site preparation for a two-well development pad in the SWISH Area of Interest, with drilling set to begin in May 2026 targeting key formations in the Anadarko Basin.

Pioneer Minerals has secured membership in the US Defense Industrial Base Consortium, positioning its Idaho-based North Pine tungsten project at the heart of critical mineral supply chain initiatives.